Thuret R, Kleinclauss F, Terrier N, Timsit M O
Service d'urologie et transplantation rénale, CHU de Montpellier, 34090 Montpellier, France; Université de Montpellier, 34090 Montpellier, France.
Service d'urologie et transplantation rénale, CHRU de Besançon, 25030 Besançon, France; Université de Franche-Comté, 25030 Besançon, France; Inserm UMR 1098, 25030 Besançon, France.
Prog Urol. 2016 Nov;26(15):909-939. doi: 10.1016/j.purol.2016.08.021. Epub 2016 Oct 8.
To review epidemiologic data's and medical results of deceased donation in renal transplantation.
Relevant publications were identified through Medline (http://www.ncbi.nlm.nih.gov) and Embase (http://www.embase.com) database using the following keywords, alone or in association, "brain death; cardiac arrest; deceased donation; organ procurement; transplantation". Articles were selected according to methods, language of publication and relevance. The reference lists were used to identify additional historical studies of interest. Both prospective and retrospective series, in French and English, as well as review articles and recommendations were selected. In addition, French national transplant and health agencies (http://www.agence-biomedecine.fr and http://www.has-sante.fr) databases were screened using identical keywords. A total of 2498 articles, 8 official reports and 17 newspaper articles were identified; after careful selection 157 publications were eligible for our review.
Deceased donation may involve either brain death or non-heartbeating donors (NHBD). Organ shortage led to the procurement of organs from expanded-criteria donors, with an increased age at donation and extended vascular disease, leading to inferior results after transplantation and underlining the need for careful donor management during brain death or cardiac arrest. Evolution of French legislation covering bioethics allowed procurement from Maastricht categories II and recently III non-heartbeating donors.
The increase of organ shortage emphasizes the need for a rigorous surgical technique during procurement to avoid loss of transplants. A history or current neoplasm in deceased-donors, requires attention to increase the pool of organs without putting the recipients at risk for cancer transmission. French NHBD program, especially from Maastricht category III, may stand for a potential source of valuable organs.
回顾肾移植中尸体供肾的流行病学数据及医学结果。
尸体供肾可涉及脑死亡或非心脏跳动供体(NHBD)。器官短缺导致从扩大标准供体获取器官,供体年龄增加且血管疾病范围扩大,导致移植后结果较差,并突出了在脑死亡或心脏骤停期间进行仔细供体管理的必要性。法国生物伦理立法的演变允许从马斯特里赫特分类II级以及最近的III级非心脏跳动供体获取器官。
器官短缺的增加强调了在获取过程中需要严格的手术技术以避免移植失败。尸体供体有既往或当前肿瘤病史时,需要加以关注,以增加器官来源同时不使受者有癌症传播风险。法国的NHBD项目,尤其是来自马斯特里赫特分类III级的项目,可能是有价值器官的潜在来源。